natgillin/translations-raw huggingface dataset:
Composition for the use according to any one of claims 1 to 12, wherein the red blood cells encapsulating a tumour antigen have been prepared by lysis-resealing. 
Pripravak za uporabu u skladu s bilo kojim od zahtjeva 1 do 12, naznačen time da su crvene krvne stanice koje inkapsuliraju tumorski antigen pripremljene pomoću liziranja-ponovnog zatvaranja.
A method of decoding an image, the method comprising: performing entropy-decoding to obtain quantized transformation coefficients of at least one transformation unit (870) in a coding unit (810); 
Uređaj (500, 1500) za dekodiranje slike, te uređaj sadrži: entropijski dekoder (520, 1510) koji provodi entropijsko dekodiranje za dobivanje kvantiziranih transformacijskih koeficijenata najmanje jedne transformacijske jedinice (870) u kodirajućoj jedinici (810);
A process for dyeing or printing materials, wherein the material is brought into contact with a compound of formula (1) according to any of claims 1 to 8 or prepared according to claim 8 or 9. A product or paper obtainable by a process according to claim 14. 
Postupak za bojenje ili tiskanje materijala koji sadrži celulozni i / ili lignocelulozni materijal, naznačen time, da materijal dolazi u doticaj sa spojem formule (1) prema bilo kojem od zahtjeva 1 do 7 ili se priprema u skladu s patentnim zahtjevom 8, pri čemu je korišteni materijal papir ili karton.
A protein having at least 70% identity, preferably 80% identity, most preferably 90 % identity, most highly preferably 95 % identity to SEQ ID NO. 
Stanica kvasca koja daje informaciju o proteinu koji sadrži aminokiselinsku sekvencu koji ima najmanje 80% identičnosti, poželjno 90% identiteta, najpoželjnije 95% identičnosti sa SEQ ID br.
The eukaryotic cell of claim 6, wherein the eukaryotic cell is a yeast cell, preferably selected from the group of Pichia, Pachysolen, Yarrowia, Saccharomyces, Candida, Arxula, Ashbya, Debaryomyces, Hansenula, Hartaea, Kluyveromyces, Schwanniomyces, Trichosporon, Xanthophylomyces, Schizosaccharomyces, Zygosaccharomyces, most preferably being Saccharomyces cerevisiae. 
Stanica kvasca iz bilo kojeg od zahtjeva od 1 do 6, naznačena time da je stanica kvasca odabrana iz grupe Pichia, Pachysolen, Yarrowia, Saccharomyces, Candida, Arxula, Ashbya, Debaryomyces, Hansenula, Hartaea, Kluyveromyces, Schwanniomyces, Trichosporon, Xantophylomyces, Schizosaccharomyces, Zygosaccharomyces, a najpoželjnije da bude Saccharomyces cerevisiae.
Process for producing a fermentation product selected from the group of lactic acid, acetic acid, succinic acid, amino acids, 1, 3-propane-diol, ethylene, glycerol, ß-lactam antibiotics, cephalosporins, biofuels, butanol, ethanol, lactic acid, itaconic acid, preferably butanol, most preferably ethanol whereby the process comprises the steps of: 
Postupak za proizvodnju fermentirajućeg proizvoda odabranog iz grupe mliječne kiseline, octene kiseline, sukcinske (jantarne) kiseline, amino kiselina, 1, 3-propan-diola, etilena, glicerola, β-laktam antibiotika, cefalosporina, biogoriva, butanola, etanola, mliječne kiseline, itakonične kiseline, poželjno butanola, a najbolje etanola naznačen time da postupak sadrži sljedeće korake:
The method according to claim 1, wherein said operational mode is indicated by an indication signal, such as e.g. a green light, a green signal plate or the like. 
Metoda u skladu sa patentnim zahtjevom 1, gdje je navedeni operativni način rada naznačen pomoću indikacijskog signala, kao što je na primjer zeleno svijetlo, zelena signalna tabla ili slično.
The method according to claim 4, wherein said rinsing mode is indicated by an indication signal, such as e.g. a red light, a red signal plate or the like. 
Metoda u skladu sa patentnim zahtjevom 4, gdje je navedeni način rada pranja naznačen indikacijskim signalom, kao što su crveno svijetlo, crvena signalna tabla ili slično.
The method according to any of claims 4-7, wherein said rinsing cartridge (20,118,132) is detachably installed onto said pressure chamber (10), or alternatively said rinsing cartridge (20,118,132) constitutes a separate rinsing unit. 
Metoda u skladu sa bilo kojim od patentnih zahtjeva 4-7, gdje je navedeni spremnik za pranje (20, 118, 132) odvojivo instaliran na navedenu komoru za pritisak (10), ili alternativno navedeni spremnik za pranje (20,118,132) predstavlja odvojenu jedinicu za pranje.
The method according to any of claims 4-8, wherein said rinsing cartridge (20,118,132) is pressurized by said enabling pressure, or further comprising said rinsing cartridge (20,118,132) being pressurized by said fluid pressure source (112) or said pressure chamber (10). 
Metoda u skladu sa bilo kojim od patentnih zahtjeva 4-8, gdje je navedeni spremnik za pranje (20,118,132) stavljen pod pritisak pomoću navedenog omogućavajućeg pritiska, ili dalje sadrži navedeni spremnik za pranje (20,118,132) koji je stavljen pod pritisak pomoću spomenutog izvora pritiska fluida (112) ili navedene komore za pritisak (10).
a tube having a lumen; and a separator substance disposed within the lumen having: 
epruvetu s lumenom; i separatorsku supstancu koja se nalazi unutar lumena koji sadrži:
a gel component layer material, wherein the gel component comprises a thixotropic gel; and additionally a photocurable sealant component layer material that is distinct from the gel component layer and comprises (1) an oligomer, with (2) a photoinitiator and (3) a stabilizer. 
sloj gel materijala, naznačeno time da gel sadrži tiksotropni gel; i dodatni sloj materijala za brtvljenje putem svjetlosti koji je različit od sloja gel materijala koji sadrži (1) oligomer, s (2) fotoinicijatorom i (3) stabilizatorom.
The tube of claim 3, wherein the photocurable sealant component layer material comprises an antioxidant and is irradiation sterilizable without loss of flowability for sedimentation of the separator substance under a centrifugal force to a position between the cell-depleted phase of whole blood and the cell-enriched phase of whole blood, and for subsequent polymerization via UV curing. 
Epruveta prema zahtjevu 3, naznačeno time da sloj materijala za brtvljenje putem svjetlosti sadrži antioksidans i može se sterilizirati iradijacijom bez gubitka protočnosti za sedimentaciju separatorske supstance pod utjecajem centrifugalne sile do položaja između faze osiromašenih stanica pune krvi i faze obogaćenih stanica pune krvi, i uz naknadnu polimerizaciju putem sušenja UV svjetlošću.
The tube of any one of claims 1 to 7, wherein the photocurable sealant component layer material maintains at least one of a potassium level of the sample within 10% of an initial potassium level, and a glucose level of the sample within 5% of an initial glucose level for at least four days. 
Epruveta prema bilo kojem od zahtjeva 1 do 4, naznačeno time da sloj materijala za brtvljenje putem svjetlosti održava barem jednu razinu kalija uzorka unutar 10% od početne razine kalija, te razinu glukoze uzorka unutar 5% od početne razine glukoze u trajanju od barem četiri dana.
A method of producing a sample collection tube, comprising: disposing a gel separator component layer material, wherein the gel component comprises a thixotropic gel into the lumen of a tube; and disposing a photocurable sealant component layer material comprising (1) an oligomer, with (2) a photoinitiator and (3) a stabilizer into the lumen of the tube; and 
Metoda dobivanja epruvete za uzimanje uzoraka krvi, sadrži: nanošenje sloja gel materijala separatora, naznačeno time da gel sadrži tiksotropni gel, u lumen epruvete; i nanošenje sloja materijala za brtvljenje putem svjetlosti koji sadrži (1) oligomer, s (2) fotoinicijatorom te (3) stabilizatorom, u lumen epruvete; i izlaganje sloja materijala za brtvljenje putem svjetlosti odgovarajućem izvoru energije, naznačeno time da je izvor energije UV svjetlost, tako da se sastojak za brtvljenje putem svjetlosti polimerizira unutar 10 minuta do barem 1 na Shoreovoj 00 skali trvdoće.
The method of claim 7, further comprising disposing a sample into the lumen of the tube, and centrifuging the sample collection tube with the sample, the gel separator component layer material, and the photocurable sealant component layer material. 
Metoda prema zahtjevu 7, koja nadalje obuhvaća nanošenje uzorka u lumen epruvete, te centrifugu epruvete za uzimanje uzoraka krvi, sloja gel materijala separatora, i sloja materijala za brtvljenje putem svjetlosti.
The method of claim 7 or 8, further comprising sterilizing the sample collection tube with the gel separator component layer material and the photocurable sealant component layer material disposed therein via irradiation sterilization. 
Metoda prema zahtjevu 7 ili 8, koja nadalje obuhvaća sterilizaciju epruvete za uzimanje uzoraka krvi koja sadrži sloj gel materijala separatora i sloj materijala za brtvljenje putem svjetlosti putem iradijacije.
A synthetic thatch member (100; 200; 300; 400; 500) for use as a roofing material product, said synthetic thatch member comprising: 
Sintetski slamnati element (100; 200; 300; 400; 500) za upotrebu kao proizvod materijala za krov, te navedeni sintetski slamnati element sadrži: mnoštvo elemenata velikog lišća;
characterized in that said plurality of frond members define a first three-dimensional surface (102; 202; 302) of said thatch member and a second three-dimensional surface (103; 203; 303) of said thatch member, said first and second surfaces comprising opposing sides of said plurality of frond members; 
naznačen time da navedeno mnoštvo elemenata velikog lišća definira prvu trodimenzionalnu površinu (102; 202; 302) navedenog slamnatog elementa i drugu trodimenzionalnu površinu (103; 203; 303) navedenog slamnatog elementa, navedena prva i druga površina obuhvaćaju suprotne strane navedenog mnoštva elemenata velikog lišća;
The synthetic thatch member (100; 200; 300; 400; 500) of Claim 1, wherein a thickness of each of said plurality of frond members is approximately 1/16 of an inch, said thickness being defined at least in part by said first (102; 202; 302) and said second (103; 203; 303) three-dimensional surfaces of each of said plurality of frond members. 
Sintetski slamnati element (100; 200; 300; 400; 500) prema zahtjevu 1, naznačen time da je debljina svakog navedenog mnoštva elemenata velikog lišća približno 1/16 inča, navedena debljina je određena barem djelomično s navedenom prvom (102; 202; 302) i navedenom drugom (103; 203; 303) trodimenzionalnom površinom svakog od navedenog mnoštva elemenata velikog lišća.
A method of installation of a synthetic thatch member for use as a roofing material product, said method of installation comprising the steps of: 
Postupak postavljanja sintetskog slamnatog elementa za upotrebu kao proizvod materijala za krov, navedeni postupak postavljanja je naznačen time da sadrži korake:
providing a plurality of synthetic thatch members (100; 200; 300; 400; 500) according to claim 1, 
osiguravanje mnoštva sintetskih slamnatih elemenata (100; 200; 300; 400; 500) prema zahtjevu 1,
affixing a first one of said plurality of synthetic thatch members to an adjacently positioned portion of a roofing structure, such that said serrated portion (120; 220; 320) is oriented substantially below said fused portion (110; 210; 310), and 
učvršćivanje prvog navedenog mnoštva sintetskih slamnatih elemenata na susjedno smješteni dio krovne konstrukcije, tako da je navedeni nazubljeni dio (120; 220; 320) orijentiran uglavnom ispod navedenog spojenog dijela (110; 210; 310), i
The method of Claim 9, wherein at least a portion of said fused portion (110; 210; 310) of said second one of said plurality of synthetic thatch members (100; 200; 300; 400; 500) overlaps at least a portion of said fused portion of said first one of said plurality of synthetic thatch members by a distance of approximately five inches. 
Postupak prema zahtjevu 9, naznačen time da barem dio navedenog spojenog dijela (110; 210; 310) od navedenog drugog navedenog mnoštva sintetskih slamnatih elemenata (100; 200; 300; 400; 500) preklapa barem dio navedenog spojenog dijela navedenog prvog navedenog mnoštva sintetskih slamnatih elemenata na udaljenosti od oko pet inča.
The method of Claim 9, further comprising the step of affixing a third one of said plurality of synthetic thatch members (100; 200; 300; 400; 500) to an adjacently positioned portion of said roofing structure, such that at least a portion of said fused portion (110; 210; 310) of said third one of said plurality of synthetic thatch members is positioned substantially above said first and said second ones of said plurality of synthetic thatch members, such that at least a portion of said fused portion of said third one of said plurality of synthetic thatch members at least partially overlaps both (i) at least a portion of said fused portion of said first one of said plurality of synthetic thatch members; and (ii) at least a portion of said fused portion of said second one of said plurality of synthetic thatch members. 
Postupak prema zahtjevu 9, naznačen time da nadalje sadrži korak pričvršćivanja trećeg od navedenog mnoštva sintetskih slamnatih elemenata (100; 200; 300; 400; 500) na susjedno postavljeni dio navedene krovne konstrukcije, tako da je barem dio navedenog spojenog dijela (110; 210; 310) navedenog trećeg navedenog mnoštva sintetskih slamnatih elemenata postavljen uglavnom iznad navedenog prvog i navedenog drugog od navedenog mnoštva sintetskih slamnatih elemenata, tako da barem dio navedenog spojenog dijela navedenog trećeg navedenog mnoštva sintetskih slamnatih elemenata barem djelomično preklapa oba (i) barem dio navedenog spojenog dijela navedenog prvog navedenog mnoštva sintetskih slamnatih elemenata; i (ii) barem dio navedenog spojenog dijela navedenog drugog navedenog mnoštva sintetskih slamnatih elemenata.
The method of Claim 11, wherein at least a portion of said serrated portion (120; 220; 320) of said third one of said plurality of synthetic thatch members at least partially overlaps at least a portion of said serrated portions of said first and second ones of said plurality of synthetic thatch members. 
Postupak prema zahtjevu 11, naznačen time da barem dio navedenog nazubljenog dijela (120; 220; 320) od navedenog trećeg navedenog mnoštva sintetskih slamnatih elemenata barem djelomično preklapa barem dio navedenih nazubljenih dijelova navedenog prvog i drugog navedenog mnoštva sintetskih slamnatih elemenata.
A method of manufacturing a synthetic thatch member for use as a roofing material product, the thatch member (100; 200; 300; 400; 500) comprising a plurality of frond members, the method comprising the steps of: 
Postupak proizvodnje sintetskog slamnatog elementa za upotrebu kao proizvod materijala za krov, slamnati element (100; 200; 300; 400; 500) obuhvaća mnoštvo elemenata velikog lišća, te je postupak naznačen time da sadrži korake:
placing a molten polymer material into a mold; and 
postavljanje rastaljenog polimernog materijala u kalup; i
forming said synthetic thatch member from said molten polymer material, said synthetic thatch member being according to claim 1; 
oblikovanje navedenog sintetskog slamnatog elemenata iz navedenog rastaljenog polimernog materijala, navedeni sintetski slamnati elemenat je prema zahtjevu 1;
wherein said mold defines said structural configuration of at least said plurality of frond members, said fused portion (110; 210; 310), and said serrated portion (120; 220; 320). The method of Claim 13, wherein: 
pri čemu navedeni kalup definira navedenu strukturnu konfiguraciju barem navedenog mnoštva elemenata velikog lišća, navedenog spojenog dijela (110; 210; 310), te navedenog nazubljenog dijela (120; 220; 320).
An aqueous CO2 absorbent comprising a combination of 2-amino-2-methyl-1-propanol (AMP) and 3-aminopropanol (AP), or AMP and 4-aminobutanol (AB). 
Vodeni apsorbens CO2 koji sadrži kombinaciju 2-amino-2-metil-1-propanola (AMP) i 3-aminopropanola (AP), ili AMP i 4-aminobutanola (AB).
A gypsum slurry comprising: calcium sulfate hemihydrate; and a set accelerator, wherein the set accelerator is a slurry of ground brushite and water, and wherein the ground brushite is present in amounts of 0.015 % to 2 % by weight of the dry brushite based on the weight of dry calcium sulfate hemihydrate. 
Gipsana kaša koja sadrži: kalcij sulfat hemihidrat; i ubrzivač očvršćivanja, gdje ubrzivač očvršćivanja predstavlja kašu mljevenog brušita i vode, i gdje je mljeveni brušit prisutan u količinama od 0.015 % do 2 % mase suhog brušita na osnovu mase suhog kalcij sulfat hemihidrata.
The gypsum slurry of claim 1 wherein said brushite slurry is aged more than 24 hours before said brushite slurry is ground. 
Gipsana kaša iz patentnog zahtjeva 1 gdje navedena brušitna kaša stoji više od 24 sata prije nego što je navedena brušitna kaša samljevena.
A gypsum product comprising: a matrix of calcium sulfate dihydrate crystals with ground brushite crystals distributed throughout said matrix, wherein said ground brushite is present in amounts of 0.015 % to 2 % by weight of the dry brushite based on the weight of dry calcium sulfate hemihydrate. 
Gipsani proizvod koji sadrži: matricu kristala kalcij sulfat dihidrata sa kristalima mljevenog brušita koji su raspoređeni kroz navedeni matricu, gdje je navedeni mljeveni brušit prisutan u količinama od 0.015 % do 2 % mase suhog brušita na osnovu mase suhog kalcij sulfat hemihidrata.
A method of making a gypsum article, the method comprising: obtaining a slurry of ground brushite with water in amounts to achieve 0.015 % to 2 % by weight of dry ground brushite based on the weight of dry calcium sulfate hemihydrate.; 
Metoda izrade gipsanog predmeta, metoda koji sadrži: dobivanje kaše od mljevenog brušita sa vodom u količinama da se dostigne 0.015 % do 2 % mase suhog mljevenog brušita na osnovu mase suhog kalcij sulfat hemihidrata;
mixing the brushite slurry, calcium sulfate hemihydrate and water to form a gypsum slurry; forming a product from said gypsum slurry; and allowing the gypsum slurry to set. 
miješanje brušitne kaše, kalcij sulfat hemihidrata i vode da se dobije gipsana kaša; formiranje proizvoda od navedene gipsane kaše; i omogućavanje gipsanoj kaši da očvrsne.
The compound of formula (IA), (IB) or (IC.1) wherein 
Spoj, naznačen time, da ima formulu (IA), (IB) ili (IC.1):
Medicament combinations which contain, besides one or more compounds of a compound according to anyone of claims 1 to 16, as further active substances, one or more compounds selected from among the categories of further ENaC inhibitors, betamimetics, anticholinergics, corticosteroids, PDE4-inhibitors, LTD4-antagonists, EGFR-inhibitors, dopamine agonists, H1-antihistamines, PAF-antagonists, MAP-kinase inhibitors, MPR4-Inhibitors, iNOS-lnhibitors, SYK-Inhibitors, corrections of the cystic fibrosis transmembrane regulator (CFTR) and CFTR potentiators or double or triple combinations thereof. 
Kombinacije lijekova, naznačene time, da osim jednog ili više spojeva od spoja prema bilo kojem od zahtjeva 1 do 16, kao dodatne djelotvorne tvari, obuhvaćaju jedan ili više spojeva odabranih između sljedećih kategorija: ENaC-inhibitori, betamimetici, antiholinergici, kortikosteroidi, PDE4-inhibitori, LTD4-antagonisti, EGFR-inhibitori, dopaminski agonisti, H1-antihistamini, PAF-antagonisti, inhibitori MAP-kinaze, MPR4-Inhibitori, iNOS-inhibitori, SYK-inhibitori, korektivi transmembranskih regulatora cistične fibroze (CFTR) i CFTR-pojačivači, ili dvostruke ili trostruke kombinacije od navedenih.
represents amino, sulfonic, carboxyl, hydroxyl, or methoxy groups; wherein R1 is attached to the aromatic ring at any position; 
predstavlja amino, sulfonsku, karboksilnu, hidroksilnu ili metoksi skupinu; pri čemu je R1 vezan na aromatski prsten u bilo kojem položaju;
and R8 are defined as described above. 
i R8 su definirani kako je opisano gore.
Use of a compound of formula (1) according to any of claims 1 to 7, for dyeing or printing materials containing cellulose and/or lignocellulosic material, wherein the material used is paper or board. 
Upotreba spoja formule (1) prema bilo kojim od patentnih zahtjeva 1 do 7, naznačen time da se koristi za bojenje ili tiskanje materijala koji sadrže celulozni i / ili lignocelulozni materijal, pri čemu je materijal koji se koristi papir ili karton.
A process for dyeing or printing materials materials containing cellulose and/or lignocellulosic material, wherein the material is brought into contact with a compound of formula (1) according to any of claims 1 to 7 or prepared according to claim 8, and wherein the material used is paper or board. 
Postupak za bojenje ili tiskanje materijala koji sadrži celulozni i / ili lignocelulozni materijal, naznačen time, da materijal dolazi u doticaj sa spojem formule (1) prema bilo kojem od zahtjeva 1 do 7 ili se priprema u skladu s patentnim zahtjevom 8, pri čemu je korišteni materijal papir ili karton.
A serum albumin binding antibody or fragment according to claim 1 or claim 2, where the antibody or fragment is selected from the group consisting of a Fab, modified Fab, Fab', F(ab')2, Fv, single variable domain antibody, scFv, bi, tri or tetra-valent antibody, Bis-scFv, diabody, triabody, tribody, DVD-Ig and BiTE. 
Protutijelo koje veže serumski albumin ili njegov fragment prema zahtjevu 1 ili zahtjevu 2, naznačeno time da je protutijelo ili fragment odabrano iz skupine koja sadrži Fab, modificirani Fab, Fab', F(ab')2, Fv, protutijelo jednostruke varijabilne domene, scFv, dvo, tro ili četvero-valentno protutijelo, Bis-scFv, diatijelo, triatijelo, tritijelo, DVD-Ig i BiTE.
A T cell genetically modified to express a CAR wherein the CAR comprises (a) an antigen binding domain that is an anti-CD19 scFv (b) a costimulatory 4-1BB signaling region, and (c) a CD3 zeta signaling domain for use in a method for treating cancer in a human, wherein the anti-CD19 scFv comprises the amino acid sequence of SEQ ID NO:20 and/or the CD3 zeta signaling domain comprises the amino acid sequence of SEQ ID NO:24, and wherein the human is resistant to at least one chemotherapeutic agent. 
T stanica koja je genetski modificirana tako da eksprimira CAR, naznačena time što CAR sadrži (a) antigen-vezujuću domenu koja predstavlja anti-CD19 scFv koji sadrži aminokiselinsku sekvencu SEQ ID NO:20, (b) kostimulatornu signalnu regiju 4-1BB, i (c) signalnu domenu CD3 zeta koja sadrži aminokiselinsku sekvencu SEQ ID NO: 24, za upotrebu u postupku za liječenje karcinoma kod čovjeka, pri čemu dolazi do remisije karcinoma, i pri čemu je čovjek otporan na liječenje najmanje jednim kemoterapeutskim sredstvom.
an acute leukemia or chronic leukemia; or 
akutna leukemija ili kronična leukemija; ili
acute lymphocytic leukemia. 
akutna limfocitna leukemija.
A T cell genetically engineered to express a CAR, wherein the CAR comprises (a) an antigen binding domain that is an anti-CD19 scFv, (b) a costimulatory 4-1BB signaling region, and (c) a CD3 zeta signaling domain, for use in a method for treating cancer that comprises administering said T cell to a human diagnosed with cancer, wherein the anti-CD19 scFv comprises the amino acid sequence of SEQ ID NO:20 or the CD3 zeta signaling domain comprises the amino acid sequence of SEQ ID NO:24, and wherein said method generates a population of genetically engineered T cells that persists in the human for at least eight months, nine months, ten months, eleven months, twelve months, two years, or three years after administration, and wherein the human is resistant to at least one chemotherapeutic agent. 
T stanica koja je genetski modificirana tako da eksprimira CAR, naznačena time što CAR sadrži (a) antigen-vezujuću domenu koja predstavlja anti-CD19 scFv koji sadrži aminokiselinsku sekvencu SEQ ID NO:20, (b) kostimulatornu signalnu regiju 4-1BB, i (c) signalnu domenu CD3 zeta koja sadrži aminokiselinsku sekvencu SEQ ID NO: 24, za upotrebu u postupku za liječenje karcinoma koji obuhvaća primjenu navedene T stanice kod čovjeka kome je dijagnosticiran karcinom, pri čemu navedeni postupak stvara populaciju genetski modificiranih T stanica koje perzistiraju u čovjeku najmanje osam mjeseci, devet mjeseci, deset mjeseci, jedanaest mjeseci, dvanaest mjeseci, dvije godine, ili tri godine nakon primjene, i pri čemu je čovjek otporan na liječenje najmanje jednim kemoterapeutskim sredstvom.